Metformin for preventing the progression of chronic kidney disease

Ragada El-Damanawi, Andrea K. Viecelli, Elaine M. Pascoe, Jonathan C. Craig, David W. Johnson, Andrew J. Mallett, Carmel M. Hawley, Thomas F. Hiemstra

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review aims to assess the effect of metformin therapy on kidney function in patients with CKD. The safety and dose tolerability of metformin use in this population will also be assessed.

Original languageEnglish
Article numberCD013414
Number of pages13
JournalCochrane Database of Systematic Reviews
Volume2019
Issue number9
DOIs
Publication statusPublished - 5 Sep 2019

Keywords

  • metformin
  • kidney function
  • chronic kidney disease (CKD)

Fingerprint Dive into the research topics of 'Metformin for preventing the progression of chronic kidney disease'. Together they form a unique fingerprint.

  • Cite this

    El-Damanawi, R., Viecelli, A. K., Pascoe, E. M., Craig, J. C., Johnson, D. W., Mallett, A. J., Hawley, C. M., & Hiemstra, T. F. (2019). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2019(9), [CD013414]. https://doi.org/10.1002/14651858.CD013414